Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: AMSEL MEDICAL CORPORATION
Awarding agency: Department of Defense / Department of the Air Force
Funding agency: Department of Defense / Department of the Air Force
Period of performance: 2024-09-30 to 2027-04-29
Current total value of award: $7453975
Description: NON-SURGICAL CONTROL OF JUNCTIONAL AND NON-COMPRESSIBLE HEMORRHAGE VIA PERCUTANEOUSLY DELIVERED ADJUSTABLE VESSEL OCCLUSION